OKYO Pharma Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for OKYO Pharma.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Biotechs earnings growth42.4%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

Low

Last updated24 Oct 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

BST:OK11 - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/2025N/A-15N/AN/A1
3/31/2024N/A-17-9-9N/A
3/31/2023N/A-13-8-8N/A
12/31/2022N/A-11-7-7N/A
9/30/2022N/A-7-5-5N/A
6/30/2022N/A-6-5-5N/A
3/31/2022N/A-5-5-5N/A
12/31/2021N/A-5-5-5N/A
9/30/2021N/A-5-4-4N/A
6/30/2021N/A-4-3-3N/A
3/31/2021N/A-3-2-2N/A
12/31/2020N/A-2-1-1N/A
9/30/2020N/A0-1-1N/A
6/30/2020N/A-1-1-1N/A
3/31/2020N/A-2-1-1N/A
12/31/2019N/A-3N/AN/AN/A
9/30/2019N/A-5-2-2N/A
6/30/2019N/A-5-2-2N/A
3/31/2019N/A-5-2-2N/A
12/31/2018N/A-4N/AN/AN/A
9/30/2018N/A-3-2-2N/A
6/30/2018N/A-15-2-2N/A
3/31/2018N/A-28-2-2N/A
12/31/2017N/A-27N/A-1N/A
9/30/2017N/A-26N/A-1N/A
6/30/2017N/A-13N/A-1N/A
3/31/2017N/A0N/A-1N/A
12/31/2016N/A0N/A0N/A
9/30/2016N/A-1N/A0N/A
6/30/2016N/A-1N/A0N/A
3/31/2016N/A-1N/A-1N/A
9/30/2015N/A-1N/A-1N/A
6/30/2015N/A-1N/A-1N/A
3/31/2015N/A-1N/A-1N/A
12/31/2014N/A-6N/A-2N/A
9/30/2014N/A-4N/A-3N/A
6/30/2014N/A-9N/A-3N/A
3/31/2014N/A-14N/A-3N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if OK11's forecast earnings growth is above the savings rate (1%).

Earnings vs Market: Insufficient data to determine if OK11's earnings are forecast to grow faster than the German market

High Growth Earnings: Insufficient data to determine if OK11's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if OK11's revenue is forecast to grow faster than the German market.

High Growth Revenue: OK11 is forecast to have no revenue next year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if OK11's Return on Equity is forecast to be high in 3 years time


Discover growth companies